ReviewNew therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases

Add time:08/29/2019    Source:sciencedirect.com

Interleukin-2 (IL-2) is a multifunctional cytokine in immune regulation. It is essential for the differentiation, expansion and stability of CD25+Foxp3+ regulatory T (Treg) cells, which is an important factor in immune suppression and self-tolerance. Meanwhile, IL-2 also stimulate effector T (Teff) cells to promote immune responses. The opposite and diverse function of IL-2 impedes its application to boost Treg cell populations in autoimmune disease treatment. Thus, it became focus of the research to modulate IL-2 activities to enhance Treg cell functions selectively. Based on the characteristic properties of Treg cells such as constitutively expression of high affinity IL-2 receptors (IL-2Rs), multiple approaches, including IL-2/mAb complexes, IL-2 muteins and low-dose of IL-2 have emerged in recent years to selectively target Treg cells and treat autoimmunity. These therapeutic approaches have achieved favorable results in both clinical trials and experimental animal models, and provided engineering blueprints to develop novel strategies of IL-2 treatments for autoimmune diseases.

We also recommend Trading Suppliers and Manufacturers of HUMAN IL-2 (cas 110942-02-4). Pls Click Website Link as below: cas 110942-02-4 suppliers

Prev:Full paperRecombinant Newcastle disease virus (NDV/Anh-IL-2) expressing HUMAN IL-2 (cas 110942-02-4) as a potential candidate for suppresses growth of hepatoma therapy
Next:A highly sensitive electrochemical sensor for Cd(II) based on protic salt derived nitrogen and sulfur co-doped porous carbon)